Indometacin and Risk of Falling
Information source: Sint Maartenskliniek
Information obtained from ClinicalTrials.gov on October 19, 2009 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Healthy
Intervention: Indometacin (Drug)
Phase: Phase 4
Status: Recruiting
Sponsored by: Sint Maartenskliniek Official(s) and/or principal investigator(s): Jacques van Limbeek, MD, Principal Investigator, Affiliation: Sint Maartenskliniek Jaak Duysens, Prof, Study Chair, Affiliation: St Maartenskliniek and University Medical Centre St. Radboud, Nijmegen
Overall contact: Judith Hegeman, MSc, Phone: +31 24 3659958, Email: j.hegeman@maartenskliniek.nl
Summary
The purpose of this study is to determine whether indometacin has an effect on reaction
time, postural stability, and the avoidance of obstacles.
Clinical Details
Official title: Influence of Indometacin on Reaction Time, Postural Balance and the Avoidance of Obstacles in Healthy Subjects
Study design: Prevention, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Safety Study
Primary outcome: Success rate on the obstacle avoidance task
Secondary outcome: Reaction timeRoot mean square (RMS) of the velocity and amplitude of the centre of pressure (COP)
Detailed description:
A lot of (epidemiologic) research is done on causes for falls and factors contributing to
falling. Most of this research was conducted on the elderly, either community-dwelling or
institutionalised. It became clear that the elderly have a greater risk at falling because
of:
- physiological changes due to increasing age [Gerdhem et al., 2005]
- previous falls [Myers et al., 1991; Lipsitz et al., 1992]
- comorbidity (including RA) [Bergland et al., 2004; Gerdhem et al., 2005; Lawlor et al.,
2003]
- polypharmacy [Lawlor et al., 2003; Walker et al., 2005; Ziere et al., 2005] and/or
- use of specific drugs like antidepressives, benzodiazepines, vasodilators, and NSAIDs
[Cumming R, 1998; Herings RMC, 2001; Kallin K et al., 2004; Granek et al., 1987].
The relation between benzodiazepines and falling has been extensively investigated in and
affirmed by several fields of research and is practically common sense. However, the
(possible) relation between NSAIDs and falling is much less investigated, even though there
are various articles in which a higher risk of falling when using NSAIDs is stated;
sometimes the risk is even as high as with benzodiazepines [Cumming R, 1998; Granek et al.,
1987; Walker et al., 2005].
Objective of the study:
NSAIDs are drugs that are often prescribed to patients with rheumatic or orthopedic
diseases. They seem to be at a greater risk for falls than healthy persons because of their
disease, age and medication use. Therefore it is very important to keep this risk as small
as possible. In this study healthy adults are measured on reaction time, postural balance
and obstacle avoidance with and without use of indometacin or placebo. This is done in order
to gain more comprehension in the mechanism and actual risk for falls when using NSAIDs.
Eligibility
Minimum age: 50 Years.
Maximum age: 70 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Age between 50-70 years old
- Not using any non-steroidal anti-inflammatory drugs (NSAIDs) for at least 3 days
prior to the test session
Exclusion Criteria:
- Neurological or orthopedic disorders
- Poor comprehension of Dutch language
- Hearing problems
- Severe problems with heart and/or blood vessels
- Acutely existing ulcus ventriculi and/or duodeni, or history of ulcus
- Allergy against indomethacin, aspirin, or other NSAIDs
- Patients with nasal polyps reacting with an angioedema to other NSAIDs
- Severe preexisting renal and liver damage
- Co-medication
- Over 100 kg of weight
Locations and Contacts
Judith Hegeman, MSc, Phone: +31 24 3659958, Email: j.hegeman@maartenskliniek.nl
Sint Maartenskliniek, Nijmegen 6522 JV, Netherlands; Recruiting Judith Hegeman, MSc, Phone: +31 24 3659958, Email: j.hegeman@maartenskliniek.nl
Additional Information
Starting date: April 2007
Last updated: July 27, 2007
|